Nephrilin

N/A

Report date: 2025/03/20 14:57:13

Base Information

Drug NameNephrilin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStress Disorders, Traumatic, AcuteDiabetes ComplicationsKidney Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOntherix Inc
China Registration ClassN/A

Develop Information

Active CompaniesTransporin companyOntherix Inc
Inactive CompaniesN/A
Active IndicationsStress Disorders, Traumatic, AcuteNeuritis
Inactive IndicationsDiabetes ComplicationsKidney DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A